PMDA drug package insert
タダラフィル錠10mgCI「TCK」
PMDA Prescription drug · 辰巳化学株式会社 · package insert Jun 4, 2026
Key facts
| Brand names | タダラフィル錠10mgCI「TCK」, タダラフィル錠20mgCI「TCK」 |
|---|---|
| Nonproprietary names | タダラフィル |
| Companies | 製造販売元／辰巳化学株式会社, 販売元／本草製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 勃起不全治療剤 |
| Therapeutic category codes | 87259 |
| YJ codes | 259000CF2097, 259000CF3093 |
| Approval numbers | 30200AMX00409000, 30200AMX00410000 |
| Package insert edition | 第3版、10mg製剤の処方箋医薬品指定解除 |
| Package insert date | Jun 4, 2026 |
| PMDA document key | 400278_259000CF2097_2 |
| PMDA company code | 400278 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: